News and Events - ITEK - The Commercialisation Company of the University of South Australia
Latest News & Events
Biotech industry expert to head up ITEK
Business development and biotechnology industry expert Dr Stephen Rodda has been appointed as CEO of the University of South Australia's commercialisation arm, ITEK.
Aus-NZ companies sign Collaboration Agreement to develop new drugs for veterinary sector.
Australian company Ceridia Pty Ltd and New Zealand's ParaCo Technology Limited have signed an agreement to develop new drugs for the veterinary sector. Combining Ceridia's novel method of reformulating oil-soluable compounds, with ParaCo's expertise and access to animal health medicines, the intent is to develop and market novel and improved formulations for farm and domestic animals.
New SA biotech company improving therapeutic drug efficacy
A new biotechnology company focused on reformulating and developing therapeutic drugs has been formed by ITEK, the commercialisation arm of UniSA. Ceridia Pty Ltd, based in Adelaide South Australia, is commercialising a novel method of reformulating oilsoluble compounds.
ITEK shines light on path to entrepreneurship
UniSA Commercialisation agency ITEK actively assist students to gain an insight into the opportunities anc challenges of pursuing the path of entrepreneurship.
$2.52 Million Deal for CPR Pharma Services
CPR Pharma Services Pty Ltd, a spin-out from the University of South Australia, commenced trading in April 2009 after attracting funding of $2.5m from Terra Rossa Capital, ITEK Pty Ltd, and the South Australian Innovation and Investment Fund.
Welcome New Chairman
UniSA's commercial arm, ITEK, has recently welcomed John Grace as its new Chairman, bringing extensive experience in the commercial development of leading-edge science, specifically biotechnology.UniSA's commercial arm, ITEK, has recently welcomed John Grace as its new Chairman, bringing extensive experience in the commercial development of leading-edge science, specifically biotechnology.
ITEK delivers $800,000 return to UniSA
UniSA’s technology transfer arm ITEK has delivered an $800,000 dividend to the university, earned from its investment and licensing activities during 2008.
ITEK revamps website to start path to success
UniSA’s commercialisation company ITEK has relaunched its website to make it easier for university researchers to successfully start transforming their research into a profitable business.
Technology funding
This collaborative venture aims to capture university research & take it towards commercialisation, creating successful spin out companies that in turn create economic opportunities, competitiveness and growth regionally and nationally.
Research In The Real World
The Australian Research Council showcase of examples of Australian research making a difference to our lives.
Seminars
This collaborative venture aims to capture university research & take it towards commercialisation, creating successful spin-out companies that in turn create economic opportunities, competitiveness and growth regionally and nationally.
Who Should Attend?
Early career researchers and postgraduate students, from any discipline, with an interest in applied research, contracting to industry or commercialisation.
Sessions are presented by ITEK's highly experienced Commercial Team and guest speaker from Madderns Patent & Trademark Attorneys firm.
NEWS AND EVENTS
- Biotech industry expert to head up ITEK
- Aus-NZ companies sign Collaboration Agreement to develop new drugs for veterinary sector.
- New SA biotech company improving therapeutic drug efficacy
- ITEK shines light on path to entrepreneurship
- $2.52 Million Deal for CPR Pharma Services
- Welcome New Chairman
- ITEK delivers $800,000 return to UniSA
- ITEK revamps website to start path to success
- Technology funding
- Research In The Real World
- Seminars